Viewing Study NCT00700206


Ignite Creation Date: 2025-12-26 @ 2:39 PM
Ignite Modification Date: 2025-12-26 @ 2:39 PM
Study NCT ID: NCT00700206
Status: COMPLETED
Last Update Posted: 2011-10-12
First Post: 2008-06-13
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Phase 2 Study Comparing Two Dose Schedules of Telintraâ„¢ in Myelodysplastic Syndrome (MDS)
Sponsor: Telik
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module